Cargando…

Engineered Biological Entities for Drug Delivery and Gene Therapy: Protein Nanoparticles

The development of genetic engineering techniques has speeded up the growth of the biotechnological industry, resulting in a significant increase in the number of recombinant protein products on the market. The deep knowledge of protein function, structure, biological interactions, and the possibili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domingo-Espín, Joan, Unzueta, Ugutz, Saccardo, Paolo, Rodríguez-Carmona, Escarlata, Corchero, José Luís, Vázquez, Esther, Ferrer-Miralles, Neus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173510/ https://www.ncbi.nlm.nih.gov/pubmed/22093221 http://dx.doi.org/10.1016/B978-0-12-416020-0.00006-1

Ejemplares similares

Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta, Ugutz, et al.
Publicado: (2012)

Microbial factories for recombinant pharmaceuticals
por: Ferrer-Miralles, Neus, et al.
Publicado: (2009)

Biofabrication of functional protein nanoparticles through simple His-tag engineering
por: López-Laguna, Hèctor, et al.
Publicado: (2021)

Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli
por: Rueda, Fabián, et al.
Publicado: (2016)

Toxicity Profiling of Bacterial Inclusion Bodies in Human Caco-2 Cells
por: Barguilla, Irene, et al.
Publicado: (2022)

Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4
por: Serna, Naroa, et al.
Publicado: (2021)

Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine
por: Ferrer-Miralles, Neus, et al.
Publicado: (2011)

Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs
por: Céspedes, María Virtudes, et al.
Publicado: (2016)

Functional inclusion bodies produced in the yeast Pichia pastoris
por: Rueda, Fabián, et al.
Publicado: (2016)

The Poly-Histidine Tag H6 Mediates Structural and Functional Properties of Disintegrating, Protein-Releasing Inclusion Bodies
por: Sánchez, Julieta María, et al.
Publicado: (2022)

Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation
por: Serna, Naroa, et al.
Publicado: (2023)

The Diphtheria Toxin Translocation Domain Impairs Receptor Selectivity in Cancer Cell-Targeted Protein Nanoparticles
por: Voltà-Durán, Eric, et al.
Publicado: (2022)

Comparative analysis of lentiviral vectors and modular protein nanovectors for traumatic brain injury gene therapy
por: Negro-Demontel, María Luciana, et al.
Publicado: (2014)

Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol
por: Fernández, Roger, et al.
Publicado: (2022)

Editorial: High added-value nanoparticles: Rethinking and recycling cell protein waste
por: Unzueta, Ugutz, et al.
Publicado: (2022)

An In Silico Methodology That Facilitates Decision Making in the Engineering of Nanoscale Protein Materials
por: Parladé, Eloi, et al.
Publicado: (2022)

Recombinant Proteins for Assembling as Nano- and Micro-Scale Materials for Drug Delivery: A Host Comparative Overview
por: Corchero, José Luis, et al.
Publicado: (2023)

Recombinant vaccines in 2022: a perspective from the cell factory
por: de Pinho Favaro, Marianna Teixeira, et al.
Publicado: (2022)

Efficient bioactive oligonucleotide‐protein conjugation for cell‐targeted cancer therapy
por: Aviñó, Anna, et al.
Publicado: (2019)

Ion-dependent slow protein release from in vivo disintegrating micro-granules
por: Álamo, Patricia, et al.
Publicado: (2021)

Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4(+) Cancers
por: Cano-Garrido, Olivia, et al.
Publicado: (2021)

Selective delivery of T22-PE24-H6 to CXCR4(+) diffuse large B-cell lymphoma cells leads to wide therapeutic index in a disseminated mouse model
por: Falgàs, Aïda, et al.
Publicado: (2020)

Green Synthesis of Metallic Nanoparticles via Biological Entities
por: Shah, Monaliben, et al.
Publicado: (2015)

Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4(+) head and neck squamous cell carcinoma tumors
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles
por: Álamo, Patricia, et al.
Publicado: (2020)

Recombinant pharmaceuticals from microbial cells: a 2015 update
por: Sanchez-Garcia, Laura, et al.
Publicado: (2016)

A Novel CXCR4-Targeted Diphtheria Toxin Nanoparticle Inhibits Invasion and Metastatic Dissemination in a Head and Neck Squamous Cell Carcinoma Mouse Model
por: Rioja-Blanco, Elisa, et al.
Publicado: (2022)

Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

Intracellular Delivery of Biologically-Active Fungal Metabolite Gliotoxin Using Magnetic Nanoparticles
por: Comas, Laura, et al.
Publicado: (2019)

Bacterial cell factories for recombinant protein production; expanding the catalogue
por: Ferrer-Miralles, Neus, et al.
Publicado: (2013)

Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
por: Serna, Naroa, et al.
Publicado: (2022)

Engineering building blocks for self-assembling protein nanoparticles
por: Vázquez, Esther, et al.
Publicado: (2010)

Engineering precision nanoparticles for drug delivery
por: Mitchell, Michael J., et al.
Publicado: (2020)

Interaction of Iron Oxide Nanoparticles with Macrophages Is Influenced Distinctly by “Self” and “Non-Self” Biological Identities
por: Portilla, Yadileiny, et al.
Publicado: (2023)

Enhanced recombinant protein capture, purity and yield from crude bacterial cell extracts by N-Lauroylsarcosine-assisted affinity chromatography
por: Carratalá, Jose Vicente, et al.
Publicado: (2023)

Artificial Inclusion Bodies for Clinical Development
por: Sánchez, Julieta M., et al.
Publicado: (2019)

Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4(+) Diffuse Large B-Cell Lymphoma Cells
por: Falgàs, Aïda, et al.
Publicado: (2021)

T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo
por: Núñez, Yáiza, et al.
Publicado: (2023)

Self-Assembled Nanobodies as Selectively Targeted, Nanostructured, and Multivalent Materials
por: Sánchez-García, Laura, et al.
Publicado: (2021)

Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic Platform
por: Palacio-Castañeda, Valentina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fvmpp8ddu9f0c0fkqcks53pdfv